Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to measure the concentrations of two anti-epileptic drugs
(Eslicarbazepine acetate and oxcarbazepine) and their metabolites in the cerebrospinal fluid
and blood plasma of healthy subjects and also to assess how these drugs are tolerated.